Cadista Pharmaceuticals Inc., the USA based subsidiary of Jubilant Organosys has its US FDA approved manufacturing facility for solid dosage forms at Salisbury, Maryland, USA. This facility has the capacity to produce 650 million tablets and 47 million capsules per annum on a single shift basis per day. The expansion of its facility to double the capacity is underway.

Jubilant Organosys has also set up a dosage forms manufacturing facility at Roorkee, India. The facility is purpose built to comply with regulatory standards desired by various regulatory agencies like US FDA, MHRA, TGA, MCC etc